S-Palmitoylation Regulates The Function Of The Mitochondria-Associated Endoplasmic Reticulum Membrane To Alleviate The Senescence Of Nucleus Pulposus Cells
Our bodies are complex, and even tiny changes at the cellular level can have big impacts on our health. Recent research sheds light on a fascinating process that could be key to understanding and potentially treating age-related conditions, particularly those affecting our spinal discs.
At the heart of this discovery is a process called S-palmitoylation, which is like adding a temporary fatty tag to proteins. This tag helps proteins do their jobs, including influencing how different parts of a cell communicate. One crucial communication hub is the “mitochondria-associated endoplasmic reticulum membrane” (MAMs). Think of MAMs as tiny bridges connecting the cell’s powerhouses (mitochondria) with its protein and fat factory (endoplasmic reticulum). These bridges are vital for many cellular functions, including managing calcium levels and responding to stress.
The study focused on cells from the nucleus pulposus, which are found in the spongy center of our spinal discs. These cells are essential for disc health, but they can age and lose function, contributing to common problems like back pain.
Researchers found that when these spinal disc cells are under low-oxygen conditions, a common stressor in degenerating discs, the S-palmitoylation of a specific protein called IP3R is reduced. This reduction disrupts the normal function of the MAMs. When MAMs don’t work correctly, it can lead to cellular aging, or “senescence,” where cells stop dividing and can even harm surrounding healthy cells.
However, the good news is that by boosting the activity of an enzyme called DHHC6, which promotes S-palmitoylation, the researchers could restore the proper function of IP3R and MAMs. This, in turn, helped to reduce cell death, lower harmful reactive oxygen species (unstable molecules that can damage cells), improve mitochondrial health, and ultimately slow down the aging process of the spinal disc cells. This suggests that maintaining the right level of S-palmitoylation could be a promising strategy to combat cellular aging in spinal discs and potentially other tissues.
Source: link to paper